Tapewire

Nasdaq · USD

MGNX

MACROGENICS INC

Export transactions ↓
Tapewire entity
6104
SEC CIK
0001125345
Parsed reports
341

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 08, 2025 Filed Feb 12, 2025 01:20 UTC
Spitznagel ThomasSr VP, Technical Ops
Exercise / conversionCommon Stock 9,001 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-25-000013 · wk-form4_1739323240.xml · nonDerivative · entry 1

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 8, 2024 the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC
Peters Jeffrey StuartSenior VP and General Counsel
Exercise / conversionRestricted Stock Unit · Derivative 9,001 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,999

Underlying: Common Stock · 9,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC
Peters Jeffrey StuartSenior VP and General Counsel
Tax withholdingCommon Stock 3,475 $2.60 $9,035.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,526

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC
Peters Jeffrey StuartSenior VP and General Counsel
Exercise / conversionCommon Stock 9,001 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:34 UTC
Eck Stephen L.Chief Medical Officer
GrantRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000020 · wk-form4_1739324076.xml · derivative · entry 4

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

F1 · derivative.exercise_price: On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:34 UTC
Eck Stephen L.Chief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 113,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000020 · wk-form4_1739324076.xml · derivative · entry 3

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,000

Underlying: Common Stock · 113,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:33 UTC
Bonvini EzioSr VP, Research & CSO
GrantRestricted Stock Unit · Derivative 21,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · derivative · entry 4

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:33 UTC
Bonvini EzioSr VP, Research & CSO
GrantEmployee Stock Option (right to buy) · Derivative 128,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · derivative · entry 3

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,000

Underlying: Common Stock · 128,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:33 UTC
Risser Eric BlasiusChief Operating Officer
GrantRestricted Stock Unit · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000018 · wk-form4_1739323980.xml · derivative · entry 4

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:33 UTC
Risser Eric BlasiusChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 120,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000018 · wk-form4_1739323980.xml · derivative · entry 3

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:30 UTC
Karrels JamesSVP, CFO and Secretary
GrantRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000017 · wk-form4_1739323818.xml · derivative · entry 4

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F4 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F4 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:30 UTC
Karrels JamesSVP, CFO and Secretary
GrantEmployee Stock Option (right to buy) · Derivative 113,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000017 · wk-form4_1739323818.xml · derivative · entry 3

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,000

Underlying: Common Stock · 113,000 shares

Expires 2035-02-07

F3 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:29 UTC
Smith Beth AnnVP, Controller & Treasurer
GrantRestricted Stock Unit · Derivative 7,850 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · derivative · entry 4

Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,850

Underlying: Common Stock · 7,850 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:29 UTC
Smith Beth AnnVP, Controller & Treasurer
GrantEmployee Stock Option (right to buy) · Derivative 47,050 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · derivative · entry 3

Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,050

Underlying: Common Stock · 47,050 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:20 UTC
Spitznagel ThomasSr VP, Technical Ops
GrantRestricted Stock Unit · Derivative 18,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000013 · wk-form4_1739323240.xml · derivative · entry 4

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:20 UTC
Spitznagel ThomasSr VP, Technical Ops
GrantEmployee Stock Option (right to buy) · Derivative 105,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000013 · wk-form4_1739323240.xml · derivative · entry 3

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:19 UTC
Peters Jeffrey StuartSenior VP and General Counsel
GrantRestricted Stock Unit · Derivative 18,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:19 UTC
Peters Jeffrey StuartSenior VP and General Counsel
GrantEmployee Stock Option (right to buy) · Derivative 105,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
October 07, 2024 Filed Oct 9, 2024 20:26 UTC
Koenig ScottDirector · President and CEO
GiftCommon Stock 53,265 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-24-000155 · wk-form4_1728505591.xml · nonDerivative · entry 2

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · The Koenig 2024 Irrevocable Trust

Disclosed balance after: 427,480

F1 · price: Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein.

Read SEC document
October 07, 2024 Filed Oct 9, 2024 20:26 UTC
Koenig ScottDirector · President and CEO
GiftCommon Stock 53,265 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-24-000155 · wk-form4_1728505591.xml · nonDerivative · entry 1

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein.

Read SEC document
September 23, 2024 Filed Sep 25, 2024 20:35 UTC
Koenig ScottDirector · President and CEO
GiftCommon Stock 374,215 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-24-000153 · wk-form4_1727296509.xml · nonDerivative · entry 2

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · The Koenig 2024 Irrevocable Trust

Disclosed balance after: 374,215

F1 · price: Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership, and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein.

Read SEC document
September 23, 2024 Filed Sep 25, 2024 20:35 UTC
Koenig ScottDirector · President and CEO
GiftCommon Stock 374,215 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-24-000153 · wk-form4_1727296509.xml · nonDerivative · entry 1

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 703,413

F1 · price: Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership, and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:18 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000134 · wk-form4_1716499104.xml · derivative · entry 2

SIEGEL JAY PHILIP · CIK 0001722857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:18 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000134 · wk-form4_1716499104.xml · derivative · entry 1

SIEGEL JAY PHILIP · CIK 0001722857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:18 UTC GrantStock Option (right to buy) · Derivative 17,077 $3.66 Strike: $4.26 $62,501.82
Disclosure

SEC source: 0001125345-24-000133 · wk-form4_1716499080.xml · derivative · entry 3

Chhabra Meenu · CIK 0001534200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,577

Underlying: Common Stock · 17,077 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

F4 · derivative.underlying_shares: At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:18 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000133 · wk-form4_1716499080.xml · derivative · entry 2

Chhabra Meenu · CIK 0001534200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:18 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000133 · wk-form4_1716499080.xml · derivative · entry 1

Chhabra Meenu · CIK 0001534200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000132 · wk-form4_1716499067.xml · derivative · entry 2

O'Brien Federica F. · CIK 0001140119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000132 · wk-form4_1716499067.xml · derivative · entry 1

O'Brien Federica F. · CIK 0001140119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC
Liu MargaretDirector
GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000131 · wk-form4_1716499040.xml · derivative · entry 3

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC
Liu MargaretDirector
GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000131 · wk-form4_1716499040.xml · derivative · entry 2

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC
Liu MargaretDirector
GrantEmployee Stock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000131 · wk-form4_1716499040.xml · derivative · entry 1

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000130 · wk-form4_1716499019.xml · derivative · entry 2

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:17 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000130 · wk-form4_1716499019.xml · derivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000129 · wk-form4_1716499006.xml · derivative · entry 2

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000129 · wk-form4_1716499006.xml · derivative · entry 1

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000128 · wk-form4_1716498992.xml · derivative · entry 2

HEIDEN WILLIAM K · CIK 0001214939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000128 · wk-form4_1716498992.xml · derivative · entry 1

HEIDEN WILLIAM K · CIK 0001214939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000127 · wk-form4_1716498965.xml · derivative · entry 2

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000127 · wk-form4_1716498965.xml · derivative · entry 1

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantStock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000126 · wk-form4_1716498951.xml · derivative · entry 2

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F3 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 21, 2024 Filed May 23, 2024 21:16 UTC GrantRestricted Stock Unit · Derivative 6,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000126 · wk-form4_1716498951.xml · derivative · entry 1

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F2 · derivative.expiration_date: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

Read SEC document
May 21, 2024 Filed May 24, 2024 21:08 UTC Amendment
Liu MargaretDirector
GrantEmployee Stock Option (right to buy) · Derivative 16,500 $0.00 Strike: $4.26 $0.00
Disclosure

SEC source: 0001125345-24-000136 · wk-form4a_1716584891.xml · derivative · entry 1

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2034-05-21

F1 · security: This transaction was inadvertently included on a previously filed Form 4 and should be deleted.

F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000109 · wk-form4_1716410067.xml · derivative · entry 2

SIEGEL JAY PHILIP · CIK 0001722857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000109 · wk-form4_1716410067.xml · nonDerivative · entry 1

SIEGEL JAY PHILIP · CIK 0001722857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000108 · wk-form4_1716410055.xml · derivative · entry 2

HEIDEN WILLIAM K · CIK 0001214939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000108 · wk-form4_1716410055.xml · nonDerivative · entry 1

HEIDEN WILLIAM K · CIK 0001214939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000107 · wk-form4_1716410040.xml · derivative · entry 2

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:34 UTC Exercise / conversionCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000107 · wk-form4_1716410040.xml · nonDerivative · entry 1

Jackson Scott Thomas · CIK 0001566617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:33 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000106 · wk-form4_1716410028.xml · derivative · entry 2

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.